Sector
PharmaceuticalsOpen
₹34.21Prev. Close
₹32.59Turnover(Lac.)
₹19.93Day's High
₹34.21Day's Low
₹32.0552 Week's High
₹7052 Week's Low
₹26.51Book Value
₹14.83Face Value
₹10Mkt Cap (₹ Cr.)
31.49P/E
0EPS
0Divi. Yield
015 Jul 2025
12:00 AM
Board Meeting
Agenda : Audited Result
12 Sep 2024
12:00 AM
AGM
Announcement Date: 12 Sep, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 9.22 | 9.22 | 9.22 | 9.22 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 25.51 | 24.46 | 24 | 17.4 |
Net Worth | 34.73 | 33.68 | 33.22 | 26.62 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 |
|---|---|---|
Revenue | 243.47 | 0 |
yoy growth (%) | 0 | |
Raw materials | -198.11 | 0 |
As % of sales | 81.36 | 0 |
Employee costs | -5.57 | 0 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 |
|---|---|---|
Profit before tax | 4.05 | -0.01 |
Depreciation | -1.8 | 0 |
Tax paid | -2.27 | 0 |
Working capital | 20.32 | |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 |
|---|---|---|
Growth matrix (%) | ||
Revenue growth | 0 | |
Op profit growth | -73,470.7 | |
EBIT growth | -60,673.29 | |
Net profit growth | -16,135.75 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,706.7 | 95.71 | 4,09,218.58 | 753.53 | 0.94 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,595.5 | 79.35 | 1,75,226.52 | 667 | 0.45 | 2,536 | 561.08 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,741.9 | 63.7 | 1,26,637.21 | 551 | 0.16 | 2,567 | 224.34 |
Cipla Ltd CIPLA | 1,554.6 | 24.3 | 1,25,540.69 | 1,303.13 | 1.03 | 4,501.66 | 397.39 |
Dr Reddys Laboratories Ltd DRREDDY | 1,270.3 | 15.39 | 1,06,062.83 | 2,961.2 | 0.63 | 7,788.7 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Gaddam Venkata Ramana
Whole Time Director & Chief Financial Officer
Bhupathiraju S Raju
Chairman & Independent Director
Dilip V Acharekar
Independent Director
Hari Priya Yerukalapudi
Company Sec. & Compli. Officer
Rameshkumar Bandari
Non Executive Director
Alluri Ranga Raju
SyNo 11/A3 Saheb Nagar KurduVi,
Chintal Kunta Eshwaramma LB Nr,
Telangana - 500074
Tel: 91-40-24128833
Website: http://www.vineetlabs.co.in
Email: cs@vineetlabs.co.in
12-10-167,
Bharath Nagar,
Hyderbad - 500018
Tel: 91-040-23818475/76/2
Website: www.vccilindia.com
Email: info@vccilindia.com
Summary
Vineet Laboratories Limited (Formerly known as Ortin Laboratories Limited) is a manufacturing company of intermediates useful for the manufacture of active pharmaceutical ingredients. The Company was ...
Read More
Reports by Vineet Laboratories Ltd
What is the Vineet Laboratories Ltd share price today?
What is the Market Cap of Vineet Laboratories Ltd?
What is the PE and PB ratio of Vineet Laboratories Ltd?
What is the 52 Week High and Low of Vineet Laboratories Ltd?
What is the CAGR of Vineet Laboratories Ltd?
What is the shareholding pattern of Vineet Laboratories Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.